Japanese Clinical Practice Guideline for Diabetes 2019 Eiichi ArakiAtsushi GotoNarihito Yoshioka Guideline 24 July 2020 Pages: 165 - 223
Medical nutrition therapy and dietary counseling for patients with diabetes-energy, carbohydrates, protein intake and dietary counseling Toshimasa YamauchiHideki KamiyaTatsuya Kondo Consensus Report 25 July 2020 Pages: 224 - 239
Ethics and practical mitigations for ongoing clinical trials during the COVID-19 pandemic Shota SuzukiYukie ItoMasato Kasahara Commentary 19 June 2020 Pages: 240 - 241
Current understanding of the effect of sodium–glucose co-transporter-2 inhibitors in Asian patients with diabetes mellitus Hirotaka Watada Introduction to Mini-Reviews 08 June 2020 Pages: 242 - 244
Significance of SGLT2 inhibitors: lessons from renal clinical outcomes in patients with type 2 diabetes and basic researches Munehiro KitadaTaro HiraiDaisuke Koya Mini-Review 11 June 2020 Pages: 245 - 251
Promising roles of sodium–glucose cotransporter 2 inhibitors in heart failure prevention and treatment Atsushi TanakaKoichi Node Mini-Review 11 June 2020 Pages: 252 - 260
Work-related, personal, and diabetes-related factors relevant to dropout from outpatient diabetes treatment visits among Japanese male employees with diabetes Nao SonodaSoichiro WatanabeAkiko Morimoto Original Article 16 December 2019 Pages: 261 - 268
Pathophysiology of gestational diabetes mellitus in lean Japanese pregnant women in relation to insulin secretion or insulin resistance Shigeru InoueYutaka KozumaKimio Ushijima Original Article 08 February 2020 Pages: 269 - 273
Efficacy and safety of a combination of an insulin secretagogue and a dipeptidyl peptidase-4 inhibitor in Japanese patients with type 2 diabetes mellitus; the repaglinide glucose oscillation study in Fukuoka (REGO-F) Yuichi TerawakiChikayo IwayaCollaborators in the Repaglinide Glucose Oscillation Study in Fukuoka (REGO-F) trial Original Article 14 February 2020 Pages: 274 - 282
Turkish version of the Michigan Neuropathy Screening Instrument in the assessment of diabetic peripheral neuropathy: a validity and reliability study Serdar KaymazHakan AlkanVeli Çobankara Original Article 21 February 2020 Pages: 283 - 292
Plasma lipopolysaccharide binding protein level statistically mediates between body mass index and chronic microinflammation in Japanese patients with type 1 diabetes Hirotaka WatanabeTakashi KatsuraIichiro Shimomura Short Communication 09 March 2020 Pages: 293 - 297